openPR Logo
Press release

EURONAV NV: FIRST SEMESTER RESULTS

07-25-2007 04:25 PM CET | Logistics & Transport

Press release from: Euronav NV

/ PR Agency: Impress Communications Ltd
ANTWERP, Belgium, 24th July 2007 – The executive committee of Euronav NV (EURONEXT: EURN) today reported its unaudited financial results for the six months ended 30th June 2007.

The company had net income of USD 134.2 million (2006: USD 124.7 million) or USD 2.55 (2006: USD 2.37) per share, for the six months ended 30th June 2007. For the six months ended 30th June 2007, EBITDA was USD 250.9 million (2006: USD 224.7 million).

The average VLCC daily time charter equivalent (TCE) rates obtained by the company’s owned fleet was around USD 56,250/day in the second quarter (2006: USD 51,750/day and USD 54,600/day for the first semester (2006: USD 67,000/day).

The time charter earnings of the Suezmax fleet which is fixed on long term time charters, was USD 34,000/day for the second quarter (2006: USD 33,550/day) and USD 34,850/day for the first semester (2006: USD 32,600/day).

Against seasonal expectation, the freight market in the second quarter was higher than in the first quarter. This was due to a strong crude oil demand from China and a much higher number of VLCC being converted for offshore projects.

In the second quarter and as previously announced, the owners of the VLCC Shinyo Landes (1993 - 306,474 dwt) have decided to exercise an option to terminate the time charter contract against a compensation of USD 20.8 million. Euronav also sold the double-hull VLCC Savoie (1993 - 306,430 dwt), for USD 82.2 million. The capital gain of this sale transaction was about USD 44.4 million. Those two transactions demonstrate Euronav’s commitment to its program of fleet renewal and the strategy to maintain a young fleet.

Two of Euronav’s VLCC, the Luxembourg (1999 – 299,150 dwt) and the Algarve (1999 – 298,969 dwt) which were on time charter out for the last five and a half years will be redelivered to Euronav during the 3rd quarter and placed into the Tankers International pool where they will be traded on the spot market.

In recent weeks the market has softened noticeably following a much anticipated seasonal trend. The outlook for the rest of the year remains nevertheless positive with demand typically increasing toward the end of the third and during the fourth quarter as a result of both weather disruptions and seasonal heating demand.

Contact:
Mr. Hugo De Stoop
Deputy CFO
Belgica House
De Gerlachekaai 20
BE 2000 Antwerpen 1
Tel: +32 3 247 44 11

FULL DETAILS OF THE RESULTS ARE POSTED ON THE EURONAV CORPORATE WEBSITE: www.euronav.com

Euronav is one of the world's leading independent crude oil tanker companies. Prior to the demerger, Euronav was the crude oil tanker division of CMB SA, the former national shipping line of Belgium founded in 1895, which has been and continues to be successfully engaged in all aspects of shipping. Euronav is the successor in business to a joint venture between CMB and CNN Compagnie Nationale de Navigation (formerly part of Worms & Cie) - which was terminated in 1998 when CMB acquired CNN from Worms.

Impress Communications Ltd
DMR House
8-10 Cleave Avenue
Orpington
BR6 7DR
++44 (0)1689 860660
info@impresscommunications.org

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release EURONAV NV: FIRST SEMESTER RESULTS here

News-ID: 24718 • Views: 1327

More Releases from Euronav NV

FSO AFRICA UPDATE
Euronav NV (EURONEXT BRUSSELS: EURN) today announces that TI Africa Ltd, the joint venture in which OSG and Euronav NV each has a 50% interest, has received a notice of termination from Maersk Oil Qatar concerning the services contract related to the FSO Africa, a vessel currently under conversion to a Floating Storage and Offloading (FSO) service vessel. The joint venture contests the termination notice and continues to believe that
EURONAV TO RAISE USD 125 MILLION
On 4 September 2009, Euronav NV (‘Euronav’) priced its offering (the ‘Offering’) of USD 125 million fixed rate senior unsecured convertible bonds, due 2015 (the ‘Bonds’). The Bonds will be issued at 100 per cent of their principal amount and will bear interest at a rate of 6.5 per cent per annum, payable semi-annually in arrear. The initial conversion price is EUR 16.28375 (or USD 23.16852 at EUR/USD exchange rate
FIRST SEMESTER RESULTS 2009
ANTWERP, Belgium, 22nd July 2009 – The executive committee of Euronav NV (EURONEXT BRUSSELS: EURN) today reported its preliminary and unaudited financial results for the six months ended 30th June 2009. The company had a net income of USD 27.1 million (first semester 2008: USD 205.2 million) or USD 0.54 (first semester 2008: USD 3.97) per share, for the first semester 2009. EBITDA for the same period was USD 123.6 million
FIRST QUARTER RESULTS 2009 AND NEW FINANCING
The executive committee of Euronav NV (EURONEXT BRUSSELS: EURN) today reported its financial results for the three months ended 31st March 2009. The company had a net income of USD 16.8 million (first quarter 2008: USD 80.7 million) or USD 0.34 (first quarter 2008: USD 1.56) per share, for the first quarter 2009. EBITDA for the same period was USD 79 million (first quarter 2008: USD 154.2 million). The average

All 5 Releases


More Releases for USD

$100,000,000 USD job contract for travel - $3,000,000 USD referral commission.
Khoja Consultants invites companies, teams or venture capitalists for a $100,000,000 USD contract for travel. The selected company will be providing all accommodations and expenses for a 6-month long business trip around the world. Khoja Consultants expects five-star treatment including close security with private planes, hotels, secured vehicles and helicopters if necessary. More details on the job contract and application are provided at - www.KhojaConsultants.com. There is a $3,000,000
Polyurethane Dispersions Market worth USD 2.04 Billion USD by 2020
The report " Polyurethane Dispersions Market by Type (Water-Based Polyurethane Dispersions and Solvent-Based Polyurethane Dispersions), by Application (Coatings, Adhesives & Sealants, Synthetic Leather Production, Fiber Glass Sizing, and Others) - Trends & Forecasts to 2020", The global polyurethane dispersions market is projected to reach USD 2.04 Billion by 2020 at a CAGR of 6.8% between 2015 and 2020. This growth is fueled by the high potential from the textile and
Retail Analytics Market worth USD 5.1 Billion USD by 2020
According to a new market research report "Retail Analytics Market by Business Function (Marketing and Customer Analytics, Merchandizing and In-Store Analytics, Supply Chain Analytics, Strategy and Planning), by Type, by Solutions and by Services - Global Forecast and Analysis to 2020", defines and segments the global retail analytics market on the basis of business function, solutions, services, deployment types, and regions along with providing an in-depth analysis and market size
Metabolomics Market USD 1.24 Billion by 2020
The global metabolomics market is estimated to reach USD 1.24 Billion in 2020, growing at a CAGR of 15.6% from 2016 to 2020, according to a market research report Metabolomics Market 2013-2020, published by iHealthcareAnalyst, Inc. Visit the Metabolomics Market 2013-2020 report at https://www.ihealthcareanalyst.com/report/metabolomics-market/ Metabolomics is the scientific study of chemical processes involving metabolites, whereas metabolome represents the collection of all metabolites in a biological cell, tissue, organ or organism, which
Radiopharmaceuticals Market USD 350 Million by 2020
Radiopharmaceuticals Market 2013-2020 report estimates the global radiopharmaceuticals market to reach nearly USD 350 Million in 2020, at a CAGR of 4.9% from 2016 to 2020 - iHealthcareAnalyst, Inc. Visit the Radiopharmaceuticals Market 2013-2020 report https://www.ihealthcareanalyst.com/report/radiopharmaceuticals-market/ Medicinal radiocompounds or radiopharmaceuticals are a group of pharmaceutical drugs which have radioactivity and they can be used as diagnostic and therapeutic agents. Radiopharmaceuticals are used in the field of nuclear medicine as radioactive tracers
Orthobiologics Market USD 5.8 Billion by 2020
Orthobiologics Market 2013-2020 report estimates the global orthobiologics market to reach nearly USD 5.8 Billion in 2020, at a CAGR of 6.2% from 2016 to 2020 - iHealthcareAnalyst, Inc. Visit the Orthobiologics Market 2013-2020 report https://www.ihealthcareanalyst.com/report/orthobiologics-market/ The global orthobiologics market report provides market size (Revenue USD Million 2013 to 2020), market share and forecasts growth trends (CAGR%, 2016 to 2020). The global orthobiologics market segmentation is based on product types (allograft, bone